two new therapies for advanced breast cancer
February 1996
Zeneca will be promoting two new therapies for advanced breast cancer...Zoladex (goserelin implant) and Arimidex (anastrozole).
Zoladex was already on the market for treating prostate cancer and endometriosis, but now it's also approved for metastatic breast cancer...in women who have NOT yet gone through menopause.
Zoladex works by suppressing estrogen production to post-menopausal levels...to reduce the growth of estrogen-responsive tumors.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote